NLS Pharmaceutics AG
NLSP0.762USD
0.0000.00%
종가 02/06, 16:00（ET）시세는 15분 지연됩니다
3.16M시가총액
--P/E TTM
자세한 내용은 NLS Pharmaceutics AG 회사
NewcelX AG, formerly NLS Pharmaceutics AG, is a Switzerland-based company primarily engaged in the biotechnology industry. The Company focuses on the discovery and development of therapies for rare and complex central nervous system (CNS) disorders, including sleep and neurodevelopmental conditions. The Company offers products like Quilience, which is a clinical-stage pharmaceutical compound. It aims to support the treatment of narcolepsy by modulating monoamine neurotransmission and orexin receptor activity. The Company also develops product like Nolazol, a treatment candidate for Attention Deficit Hyperactivity Disorder (ADHD). The Company is a publicly traded company, listing on the NASDAQ.
NLS Pharmaceutics AG 정보
종목 코드 NLSP
회사 이름NewcelX AG
상장일Jan 29, 2021
CEOZwyer (Alexander)
직원 수1
유형Ordinary Share
회계 연도 종료Jan 29
주소The Circle 6
도시ZUERICH
증권 거래소NASDAQ Capital Market Consolidated
국가Switzerland
우편 번호8058
전화41445122150
웹사이트https://nlspharma.com/
종목 코드 NLSP
상장일Jan 29, 2021
CEOZwyer (Alexander)
NLS Pharmaceutics AG의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Ronald Hafner
Mr. Ronald Hafner
Independent Chairman of the Board
Independent Chairman of the Board
438.17K
+129669.00%
Dr. Eric Konofal, M.D., Ph.D.
Dr. Eric Konofal, M.D., Ph.D.
Chief Scientific Officer
Chief Scientific Officer
48.53K
+48528.00%
Mr. Gian-Marco Rinaldi
Mr. Gian-Marco Rinaldi
Independent Director
Independent Director
12.40K
+12399.00%
Ms. Florence Allouche Aknin
Ms. Florence Allouche Aknin
Independent Director
Independent Director
3.00K
+3005.00%
Mr. Alexander Zwyer
Mr. Alexander Zwyer
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Cindy Rizzo
Ms. Cindy Rizzo
Investor Relations
Investor Relations
--
--
Ms. Nicole Fernandez-mcgovern
Ms. Nicole Fernandez-mcgovern
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Olivier Samuel
Mr. Olivier Samuel
Independent Director
Independent Director
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Ronald Hafner
Mr. Ronald Hafner
Independent Chairman of the Board
Independent Chairman of the Board
438.17K
+129669.00%
Dr. Eric Konofal, M.D., Ph.D.
Dr. Eric Konofal, M.D., Ph.D.
Chief Scientific Officer
Chief Scientific Officer
48.53K
+48528.00%
Mr. Gian-Marco Rinaldi
Mr. Gian-Marco Rinaldi
Independent Director
Independent Director
12.40K
+12399.00%
Ms. Florence Allouche Aknin
Ms. Florence Allouche Aknin
Independent Director
Independent Director
3.00K
+3005.00%
Mr. Alexander Zwyer
Mr. Alexander Zwyer
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Cindy Rizzo
Ms. Cindy Rizzo
Investor Relations
Investor Relations
--
--
수익 분석
기업이 아직 관련 데이터를 공개하지 않았습니다.
기업이 아직 관련 데이터를 공개하지 않았습니다.
사업별
지역별
기업이 아직 관련 데이터를 공개하지 않았습니다.
주식 보유 통계
마지막 업데이트: Sat, Jan 3
마지막 업데이트: Sat, Jan 3
주주
주주 유형
주주
주주
비율
Sarl (League Jann)
21.24%
Revel (Michel)
20.22%
Hafner (Ronald)
9.61%
Clover Wolf Capital - Limited Partnership.
7.53%
Twito (Ronen)
5.41%
기타
35.99%
주주
주주
비율
Sarl (League Jann)
21.24%
Revel (Michel)
20.22%
Hafner (Ronald)
9.61%
Clover Wolf Capital - Limited Partnership.
7.53%
Twito (Ronen)
5.41%
기타
35.99%
주주 유형
주주
비율
Individual Investor
60.24%
Corporation
7.53%
Holding Company
3.54%
Investment Advisor
1.32%
Hedge Fund
0.32%
기타
27.06%
기관 주식 보유
마지막 업데이트: Thu, Jan 1
마지막 업데이트: Thu, Jan 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q4
16
74.40K
1.63%
-243.54K
2025Q3
18
223.48K
5.21%
-129.02K
2025Q2
26
1.40M
38.90%
+507.92K
2025Q1
22
894.91K
48.25%
+498.74K
2024Q4
29
1.02M
51.68%
+526.99K
2024Q3
29
831.36K
56.13%
+285.14K
2024Q2
30
615.17K
76.38%
+216.04K
2024Q1
28
605.94K
63.12%
+266.33K
2023Q4
27
460.27K
50.03%
+88.87K
2023Q3
27
471.85K
51.33%
+97.30K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
Sarl (League Jann)
968.21K
21.24%
+760.29K
+365.68%
Oct 30, 2025
Revel (Michel)
921.89K
20.22%
+732.87K
+387.74%
Oct 30, 2025
Hafner (Ronald)
438.17K
9.61%
+129.67K
+42.03%
May 22, 2025
Clover Wolf Capital - Limited Partnership.
343.12K
7.53%
+343.12K
--
Oct 30, 2025
Twito (Ronen)
246.51K
5.41%
+246.51K
--
Oct 30, 2025
Alpha Capital Aktiengesellschaft
161.29K
3.54%
-85.71K
-34.70%
May 15, 2025
Grisard (Felix)
107.37K
2.36%
+107.37K
--
Oct 15, 2024
The Lind Partners, LLC
59.78K
1.31%
-43.75K
-42.26%
Dec 31, 2024
Konofal (Eric)
48.53K
1.06%
+48.53K
--
May 15, 2025
BVF Partners L.P.
14.37K
0.32%
-129.31K
-90.00%
Oct 31, 2025
더 보기
관련 ETF
이름
비율
데이터 없음
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
Sep 25, 2024
Merger
40→1
Sep 25, 2024
Merger
40→1
Sep 25, 2024
Merger
40→1
Sep 25, 2024
Merger
40→1
날짜
배당락일
유형
비율
Sep 25, 2024
Merger
40→1
Sep 25, 2024
Merger
40→1
Sep 25, 2024
Merger
40→1
Sep 25, 2024
Merger
40→1
